Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H15N3O |
| Molecular Weight | 217.267 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC1=C(C)N(C)N(C1=O)C2=CC=CC=C2
InChI
InChIKey=JILCEWWZTBBOFS-UHFFFAOYSA-N
InChI=1S/C12H15N3O/c1-9-11(13-2)12(16)15(14(9)3)10-7-5-4-6-8-10/h4-8,13H,1-3H3
| Molecular Formula | C12H15N3O |
| Molecular Weight | 217.267 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Population pharmacokinetic analysis of the active product of dipyrone. | 2010-12 |
|
| Investigation of the microbial degradation of phenazone-type drugs and their metabolites by natural biofilms derived from river water using liquid chromatography/tandem mass spectrometry (LC-MS/MS). | 2010-08 |
|
| Scavenging activity of aminoantipyrines against hydroxyl radical. | 2010-06 |
|
| Quantification of 4-methylaminoantipyrine, the active metabolite of dipyrone, in human plasma. | 2009-05 |
|
| Treatment of postherpetic neuralgia: focus on pregabalin. | 2009 |
|
| Photodegradation study of three dipyrone metabolites in various water systems: identification and toxicity of their photodegradation products. | 2008-05 |
|
| Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis. | 2008-01 |
|
| Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury. | 2008 |
|
| [Analysis of three metabolite residues of dipyrone in bovine muscle and pork muscle using high performance liquid chromatography]. | 2007-11 |
|
| [Favorable outcome of acute porphyric neuropathy after treatment with heme arginate]. | 2007-11 |
|
| Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. | 2007-08 |
|
| Solid-phase extraction followed by liquid chromatography-time-of-flight-mass spectrometry to evaluate pharmaceuticals in effluents. A pilot monitoring study. | 2007-07 |
|
| Inhibition of cyclooxygenases by dipyrone. | 2007-06 |
|
| [Drug-induced agranulocytosis in rheumatology. A retrospective study of 12 cases]. | 2007-04-23 |
|
| Simultaneous determination of residues of dipyrone and its major metabolites in milk, bovine muscle, and porcine muscle by liquid chromatography/mass spectrometry. | 2005-04-30 |
|
| Characterization of the role of physicochemical factors on the hydrolysis of dipyrone. | 2004-05-28 |
|
| Effect of metamizol on promyelocytic and terminally differentiated granulocytic cells. Comparative analysis with acetylsalicylic acid and diclofenac. | 2003-01-15 |
|
| Allergic cholestatic hepatitis and exanthema induced by metamizole: verification by lymphocyte transformation test. | 2002-12 |
|
| Bioavailability of two metamizole (dipyrone) solutions as single doses of 2 g versus metamizole capsules. | 2002-07 |
|
| Benzydamine: an alternative nonsteroidal anti-inflammatory drug in patients with nimesulide-induced urticaria. | 2002-05 |
|
| Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | 2001-11 |
|
| Limited-sampling strategy models for estimating the pharmacokinetic parameters of 4-methylaminoantipyrine, an active metabolite of dipyrone. | 2001-11 |
|
| Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators. | 2001-09 |
|
| Acute hepatitis due to ketoprofen. | 1991-06 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:52:12 GMT 2025
by
admin
on
Mon Mar 31 18:52:12 GMT 2025
|
| Record UNII |
NER31DE951
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
519-98-2
Created by
admin on Mon Mar 31 18:52:12 GMT 2025 , Edited by admin on Mon Mar 31 18:52:12 GMT 2025
|
PRIMARY | |||
|
NER31DE951
Created by
admin on Mon Mar 31 18:52:12 GMT 2025 , Edited by admin on Mon Mar 31 18:52:12 GMT 2025
|
PRIMARY | |||
|
SUB14664MIG
Created by
admin on Mon Mar 31 18:52:12 GMT 2025 , Edited by admin on Mon Mar 31 18:52:12 GMT 2025
|
PRIMARY | |||
|
73261
Created by
admin on Mon Mar 31 18:52:12 GMT 2025 , Edited by admin on Mon Mar 31 18:52:12 GMT 2025
|
PRIMARY | |||
|
DTXSID80199865
Created by
admin on Mon Mar 31 18:52:12 GMT 2025 , Edited by admin on Mon Mar 31 18:52:12 GMT 2025
|
PRIMARY | |||
|
C008667
Created by
admin on Mon Mar 31 18:52:12 GMT 2025 , Edited by admin on Mon Mar 31 18:52:12 GMT 2025
|
PRIMARY | |||
|
10618
Created by
admin on Mon Mar 31 18:52:12 GMT 2025 , Edited by admin on Mon Mar 31 18:52:12 GMT 2025
|
PRIMARY | |||
|
208-281-3
Created by
admin on Mon Mar 31 18:52:12 GMT 2025 , Edited by admin on Mon Mar 31 18:52:12 GMT 2025
|
PRIMARY | |||
|
100000080001
Created by
admin on Mon Mar 31 18:52:12 GMT 2025 , Edited by admin on Mon Mar 31 18:52:12 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|